Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJordi Bruix, Juan Rodés, Erik Christensen et al.|Journal of Hepatology|2001Cited by 4.1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJordi Bruix, Josep M. Llovet, Jean‐Luc Raoul et al.|Journal of Hepatology|2012Cited by 821
HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosisG. Nkontchou, Michel Beaugrand, Marianne Ziol et al.|Journal of Viral Hepatitis|2011Cited by 178